Redx CEO Lisa Anson elected to Bioindustry Association board
29th Oct 2018 14:50
(Sharecast News) - Drug development company Redx Pharma noted an announcement from the UK BioIndustry Association (BIA) on Monday that Lisa Anson had been elected to serve on the BIA board of directors.
Read moreRedX Pharma as it proposes discounted capital raising
9th Feb 2017 14:21
(ShareCast News) - Shares in RedX Pharma are down almost 5% as it proposes raising £12m, before expenses, via a placing and subscription to advance its drugs pipeline. The proposed placing was of up to 20.5m shares, while the subscription was of 11.5m shares by Lanstead Capital, an institutional inv
Read moreRedx Pharma identifies candidate for inhibitor programme
20th Oct 2016 11:34
(ShareCast News) - Drug-development company Redx Pharma has identified a candidate for its reversible Bruton's tyrosine kinase (BTK) inhibitor programme. The compound, named RXC005, has the potential to treat the majority of patients suffering from chronic lymphocytic leukaemia (CLL), including tho
Read moreSunday share tips: Dunelm Group, Green REIT, Redx Pharma
11th Sep 2016 15:25
(ShareCast News) - Buy shares in Dunelm Group, said the Sunday Times' Inside the City column. On Wednesday the home furnishings retailer is due to publish its first annual results under new chief executive John Browett. In the final three months of the year the FSTE 250 company - a sort of cut-price
Read moreNew Redx director brings scientific, commercial expertise
4th Jan 2016 08:35
(ShareCast News) - Redx announced the appointment of a non-executive director on Monday, with Dr Bernhard Kirschbaum joining the firm's board immediately. The AIM-listed self-described drug discovery and development company said Dr Kirschbaum was bringing with him more than 25 years experience in ph
Read moreRedx Pharma enjoys good progress during first-half
22nd Jun 2015 14:17
Two months after its admission to AIM, Redx Pharma said its first-half results were in line with expectations thanks to progress on potential MRSA drugs. Losses before tax rose 60.5% to £3.26m due to a decrease in grant funding and operating expenses increased 5% to £5.48m. The drug discovery and d
Read moreRedx Pharma cheers with progress on potential MRSA drug
2nd Jun 2015 11:13
Redx shares jumped on the news it has reached the pre-clinical development stage with a new anti-infective compound designed to tackle MRSA, the bacteria that causes potentially lethal infections in humans. The pharmaceutical firm said the progress marked a "significant milestone" for its commercial
Read moreRedx Pharma enjoys successful AIM debut
27th Mar 2015 09:43
Shares in pharmaceutical development company Redx Pharma traded at a small premium upon the company's debut on the London Stock Exchange. The Liverpool-based group began trading on AIM on Friday, having raised £15m in gross proceeds after placing 17.6m shares at 85p each. The company, which has nom
Read more